Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(1.05) by 25.71 percent. This is a 2.63 percent decrease over losses of $(0.76) per share from the same period last year.原油配资平台原油配资平台

海量资讯、精准解读，尽在新浪财经APP